CAS No. |
161923-50-8 |
中文名称 |
6-氯-2-羟基-9-(2',3',5'-三-O-乙酰基-β-D-呋喃核糖基)嘌呤 |
英文名称 |
6-Chloro-2-hydroxy-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine |
别名 |
6-Chloro-2-hydroxy-9-(2,3,5-tri-O-acetyl)--D-ribofuranosyl-9H-purine;6-Chloro-2-hydroxy-9-(2,3,5-tri-O-acetyl)-beta-D-ribofuranosyl-9H-purine;6-Chloro-1,9-dihydro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-2H-purin-2-one;2H-Purin-2-one, 6-chloro-1,9-dihydro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-;6-Chloro-2-hydroxy-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)purine;(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-2-oxo-1H-purin-9(2H)-yl)tetrahydrofuran-3,4-diyl diacetate;6-Chloro-2-hydroxy-9-(2,3,5-tri-O-acetyl)-b-D-ribofuranosyl-9H-purine;6-Chloro-2-hydroxy-9-(2′,3′,5′-tri-O-acetyl-β-D-ribofuranosyl)purine, CAS 161923-50-8 |
标准英文名 |
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-chloro-2-oxo-1,2-dihydro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate |
分子式 |
C16H17ClN4O8 |
分子量 |
428.79
|
精确分子量 |
428.07
|
SMILES |
O=C1N=C2N([C@H]3[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O3)C=NC2=C(Cl)N1 |
标准SMILES |
CC(=O)O[C@@H]1[C@@H](COC(C)=O)O[C@H]([C@@H]1OC(C)=O)N1C=NC2C1=NC(=O)NC=2Cl |
用途 |
6-Chloro-2-hydroxy-9-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)purine is a purine nucleoside analog with broad antitumor activity, particularly targeting indolent lymphoid malignancies. Its anticancer mechanism involves inhibition of DNA synthesis and induction of apoptosis. |
InChIKey |
UDPLUTIBYLKPII-SDBHATRESA-N |